You are here: Industry Insights > BIO

News List

Provention Bio Initiates Trial Evaluating PRV-3279 in Lupus americanpharmaceuticalreview
August 09, 2019
Provention Bio has dosed the first patients in its PREVAIL (PRV-3279 EVAluation In Lupus) study, a Phase 1b/2a clinical trial evaluating PRV-3279. PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface prote
As Bernie predicted, PhRMA, BIO and Big Pharma aired ads during debate programming fiercepharma
August 08, 2019
During the second Democratic 2020 candidate debate last week, Sen. Bernie Sanders predicted healthcare industry ads during CNN commercial breaks. He wasn’t wrong.
EWIB Partners with BIO to Promote Gender Diversity on Corporate Boards biospectrumasia
June 28, 2019
The new partnership will help change the landscape of life science boardrooms by expanding executive women’s resources and visibility Executive Women in Bio (EWIB) partners with BIO to promote gender diversity on corporate boards. The new partnership will
CDMO Great Bay Bio Founded contractpharma
June 19, 2019
To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO.
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes drugs
June 13, 2019
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes.
Provention Bio Announces Top-Line Results from its PRV-300 Trial americanpharmaceuticalreview
May 10, 2019
Provention Bio Announces Top-Line Results from its PRV-300 Trial.
Congresswoman Dingell Honored as Innovator in Biotechnology biospectrumasia
April 08, 2019
BIO’s Innovator in Biotechnology award recognizes Members of Congress who have been collaborative partners, advocates, and champions of the biotechnology and life sciences industries.
Patient advocate urges BIO to boot Catalyst over its $375K Firdapse price fiercepharma
March 08, 2019
Sen. Bernie Sanders, I-Vt., isn’t the only pharma critic shining a light on relatively unknown drugmaker Catalyst Pharmaceuticals.
Goodwin Bio, Radimmune Enter Oncology Pact contractpharma
November 19, 2018
Radimmune Therapeutics has selected Goodwin Biotechnology to develop a process and manufacture it's lead therapeutic
BridgeBio Pharma Enters Genetic Disease Alliance contractpharma
November 13, 2018
BridgeBio Pharma Enters Genetic Disease Alliance

Previous page 1 2 Next page